limnw (NASDAQ:LIMNW) Stock Price & Analysis

–

USD

–(–)

Open

$0.06

Prev. Close

$0.0437

High

$0.067

Low

$0.06

Company Profile

Liminatus Pharma, Inc., situated in La Palma, California, is an immuno-oncology firm actively engaged in clinical trials, dedicated to pioneering innovative treatments for various cancers.

CEOChris Kim

SectorHealthcare

IndustryBiotechnology

Employees1

IPO DateApr 30, 2025

ExchangeNASDAQ

Exchange NameNASDAQ Global Select

CurrencyUSD

Headquarters & Contact

Address12611 Hiddencreek Way

City / State / ZIPCerritos, CA, 90703

CountryUnited States

Phone213 273 5453

Websitehttps://liminatuspharma.com

Liminatus Pharma, Inc. Warrants

Company Profile

Recently from Cashu